Citrine Global Corp. (CTGL)
OTCMKTS: CTGL · Delayed Price · USD
0.0125
0.00 (0.00%)
Apr 15, 2024, 3:11 PM EDT - Market closed
Citrine Global Revenue
Citrine Global had revenue of $309.98M in the twelve months ending September 30, 2023, down -1,822.09% year-over-year. Revenue in the quarter ending September 30, 2023 was $328.00M, a -16,500.00% decrease year-over-year. In the year 2022, Citrine Global had annual revenue of $-24.00K, a decrease of -53.85%.
Revenue (ttm)
$309.98M
Revenue Growth
-1,822.09%
P/S Ratio
0.04
Revenue / Employee
$17,220,889
Employees
18
Market Cap
13.05M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | -24.00K | 28.00K | -53.85% |
Dec 31, 2021 | -52.00K | -63.37K | -557.26% |
Dec 31, 2020 | 11.37K | -137.71K | -92.37% |
Dec 31, 2019 | 149.09K | -102.33K | -40.70% |
Dec 31, 2018 | 251.42K | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 5.85K | 24.00 | 0.41% |
Dec 31, 2014 | 5.82K | 24.00 | 0.41% |
Dec 31, 2013 | 5.80K | -16.00 | -0.28% |
Dec 31, 2012 | 5.82K | -87.09K | -93.74% |
Dec 31, 2011 | 92.91K | - | - |
Dec 31, 2010 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walmart | 648.13B |
Costco | 248.83B |
Target | 107.41B |
PepsiCo | 91.88B |
Procter & Gamble | 84.06B |
Unilever | 66.23B |
Anheuser-Busch InBev | 59.38B |
The Coca-Cola Company | 45.75B |
CTGL News
- 5 months ago - Citrine Global Corp. (CTGL) Announces Binding Agreement to Acquire 51% of iBOT Israel Botanicals, a Revenue-Generating Nutritional Supplements' Company with Fast-Growing Potential - GlobeNewsWire
- 1 year ago - Citrine Global Corp. (CTGL) Signs MOU with MyPlant Bio, Specialized in Botanical Drug Development, to Acquire 55% of MyPlant's Shares against Citrine Global Shares - GlobeNewsWire
- 1 year ago - Citrine Global Corp. (OTCQB: CTGL) Files Provisional Patent Application for Balancing Side Effects - GlobeNewsWire
- 1 year ago - Citrine Global Corp. (OTCQB: CTGL) Announced its Subsidiary Files Provisional Patent Application Targeting to Address Oral Cavity Side Effects Associated with the Use of Medicines, Treatments, Aging or an Unbalanced/Unhealthy Lifestyle - GlobeNewsWire
- 2 years ago - Citrine Global Corp. (OTCQB: CTGL) Announces Prof. Itamar Grotto, a World-Renowned Expert in Public Health, Joining the Company's Israeli Subsidiary Board of Directors, and Appointed as President of Green Vision Center Israel - GlobeNewsWire
- 2 years ago - Citrine Global CEO Issues Letter to Shareholders - GlobeNewsWire
- 2 years ago - Citrine Global Subsidiary Acquires 11,687 sqm of Industrial Land to Build its 5,500 sqm “Green Vision Center” - GlobeNewsWire
- 2 years ago - Citrine Global Corp.'s (OTCQB: CTGL) Subsidiary, Cannovation Center Israel Ltd., is Pleased to Announce the Launch of its "Green Side by Side" Products Line and the Signing of an Agreement with Intelicanna to Sell the Products in Israel - GlobeNewsWire